THC SEC Filing News — Tenet Healthcare Corporation

Latest SEC filings for Tenet Healthcare Corporation (THC) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-22.

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, mu…
Sector: Healthcare Industry: Medical Care Facilities Market Cap: $21.5B CIK: 70318
20
Total Filings
0
Bullish Classifications
11
Bearish Classifications
9
Insider Transactions
2
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for THC currently lean bearish. Of the 20 filing records displayed, 11 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
THC Filing Activity Snapshot 2026-08-06 — 2026-09-22
Insider Transactions (Form 4)
0 buys vs 8 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$27.64M
Sutaria Saumya (Director, CEO) · 2026-08-26
100,000 shares · Form 4
Form 144 Notices
9
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 9 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 9 filings in this group are Form 4s for Tenet Healthcare Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 9 insider filings shown, the breakdown is 8 open-market sale and 1 gift. 8 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×8
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Gift ×1
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Form 4 Open-market sale Insider Selling 2026-09-16

THC insider KERREY J ROBERT (Director) sold 12,010 shares (~$3.17M)

KERREY J ROBERT, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 12,010 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,483 $263.04 $1.44M
S Open-market sale 4,025 $264.10 $1.06M
S Open-market sale 2,502 $264.62 $662.1K
Filing: Form 4 (Insider Transaction) Insider: KERREY J ROBERT (Director) Shares: 12,010 Est. Value: $3.17M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-14

THC insider MARK RICHARD J (Director) sold 10,000 shares (~$2.63M)

MARK RICHARD J, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 10,000 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 10,000 $263.42 $2.63M
Filing: Form 4 (Insider Transaction) Insider: MARK RICHARD J (Director) Shares: 10,000 Est. Value: $2.63M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-03

THC insider West Nadja (Director) sold 1,152 shares (~$298.1K)

West Nadja, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 1,152 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,152 $258.80 $298.1K
Filing: Form 4 (Insider Transaction) Insider: West Nadja (Director) Shares: 1,152 Est. Value: $298.1K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-01

THC insider Foo Lisa Y (EVP, Chief Operating Officer) sold 24,000 shares (~$6.39M)

Foo Lisa Y, listed as EVP, Chief Operating Officer at TENET HEALTHCARE CORP, reported an open-market sale of 24,000 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 24,000 $266.32 $6.39M
Filing: Form 4 (Insider Transaction) Insider: Foo Lisa Y (EVP, Chief Operating Officer) Shares: 24,000 Est. Value: $6.39M
View on SEC EDGAR → Open Filing Document →
Form 4 Gift Tax / Compensation Filing 2026-08-31

THC insider Form 4 filed for equity award, exercise, or tax withholding

HANEY CECIL D (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code Nature Shares Price Value
G Gift 150 — —
Filing: Form 4 (Insider Transaction) Insider: HANEY CECIL D (Director) Shares: 150
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-26

THC insider HANEY CECIL D (Director) sold 1,300 shares (~$361.4K)

HANEY CECIL D, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 1,300 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,300 $278.03 $361.4K
Filing: Form 4 (Insider Transaction) Insider: HANEY CECIL D (Director) Shares: 1,300 Est. Value: $361.4K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-26

THC insider Sutaria Saumya (Director, CEO) sold 100,000 shares (~$27.64M)

Sutaria Saumya, listed as Director, CEO at TENET HEALTHCARE CORP, reported an open-market sale of 100,000 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 13,344 $278.17 $3.71M
S Open-market sale 36,656 $278.90 $10.22M
S Open-market sale 17,220 $273.34 $4.71M
S Open-market sale 24,881 $274.10 $6.82M
S Open-market sale 7,899 $275.26 $2.17M
Filing: Form 4 (Insider Transaction) Insider: Sutaria Saumya (Director, CEO) Shares: 100,000 Est. Value: $27.64M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-10

THC insider Romo Tammy (Director) sold 7,422 shares (~$1.95M)

Romo Tammy, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 7,422 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 4,922 $264.15 $1.30M
S Open-market sale 2,500 $260.83 $652.1K
Filing: Form 4 (Insider Transaction) Insider: Romo Tammy (Director) Shares: 7,422 Est. Value: $1.95M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-07

THC insider Blunt Roy (Director) sold 600 shares (~$157.6K)

Blunt Roy, listed as Director at TENET HEALTHCARE CORP, reported an open-market sale of 600 THC shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 600 $262.68 $157.6K
Filing: Form 4 (Insider Transaction) Insider: Blunt Roy (Director) Shares: 600 Est. Value: $157.6K
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 9 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Tenet Healthcare Corporation has 9 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-14

THC Form 144 filed for proposed insider sale by KERREY J ROBERT (12,010 shares) ~$3.21M

KERREY J ROBERT filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: KERREY J ROBERT Shares: 12,010 Est. Value: $3.21M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-10

THC Form 144 filed for proposed insider sale by MARK RICHARD J (10,000 shares) ~$2.63M

MARK RICHARD J filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MARK RICHARD J Shares: 10,000 Est. Value: $2.63M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-02

THC Form 144 filed for proposed insider sale by West Nadja (1,152 shares) ~$298.1K

West Nadja filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: West Nadja Shares: 1,152 Est. Value: $298.1K
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-08-31

THC Form 144 filed for proposed insider sale by Foo Lisa Y (24,000 shares) ~$6.39M

Foo Lisa Y filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Foo Lisa Y Shares: 24,000 Est. Value: $6.39M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-08-25

THC Form 144 filed for proposed insider sale by Sutaria Saumya (50,000 shares) ~$13.70M

Sutaria Saumya filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Sutaria Saumya Shares: 50,000 Est. Value: $13.70M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-24

THC Form 144 filed for proposed insider sale by HANEY CECIL D (1,300 shares) ~$361.4K

HANEY CECIL D filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: HANEY CECIL D Shares: 1,300 Est. Value: $361.4K
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-08-24

THC Form 144 filed for proposed insider sale by Sutaria Saumya (50,000 shares) ~$13.94M

Sutaria Saumya filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Sutaria Saumya Shares: 50,000 Est. Value: $13.94M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-07

THC Form 144 filed for proposed insider sale by Romo Tammy (2,500 shares) ~$652.1K

Romo Tammy filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Romo Tammy Shares: 2,500 Est. Value: $652.1K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-06

THC Form 144 filed for proposed insider sale by Romo Tammy (4,922 shares) ~$1.30M

Romo Tammy filed a Form 144 with the SEC indicating intent to sell THC (TENET HEALTHCARE CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Romo Tammy Shares: 4,922 Est. Value: $1.30M
View on SEC EDGAR → Open Filing Document →
Material Events 2 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 2 in this period for Tenet Healthcare Corporation. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-22

THC filed 8-K — material company event

TENET HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-09-08

THC filed 8-K — material company event

TENET HEALTHCARE CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →

How we classify Tenet Healthcare Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on THC. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — THC SEC Filings

More Tools for THC

THC Full Stock Analysis THC Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper THC analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the THC stock analysis page.

THC Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer